Critical Outcome Technologies Reports Third Quarter Results

Critical Outcome Technologies Inc. (TSX Venture: COT; OTCQB: COTQF) (“COTI” or the “Company”) reported its financial and operating results today for the three- and nine-month periods ended January 31, 2017. Major highlights for the quarter included: Commencing dosing of cohort 4 patients in the Phase 1 clinical trial of the Company’s lead drug candidate, COTI-2.…